Medicine & Life Sciences
Indoleamine-Pyrrole 2,3,-Dioxygenase
100%
Dendritic Cells
74%
enfortumab vedotin
70%
Neoplasms
50%
T-Lymphocytes
50%
Urinary Bladder Neoplasms
43%
Immunotherapy
35%
Regulatory T-Lymphocytes
32%
Immune Privilege
31%
durvalumab
31%
olaparib
28%
Sorafenib
22%
Irinotecan
21%
Adenocarcinoma
21%
B-Lymphocytes
21%
Mycobacterium bovis
21%
Cystectomy
20%
Survival
20%
Mitomycin
20%
Tetradecanoylphorbol Acetate
20%
Immunity
20%
Pancreatic Neoplasms
19%
Interferons
19%
Thyroid Neoplasms
18%
Interferon-alpha
18%
Inflammation
18%
Mental Competency
17%
Immune Tolerance
17%
Genetic Therapy
17%
Urinary Bladder
16%
Cisplatin
16%
Tissue Survival
15%
Squamous Cell Carcinoma
15%
S 6
14%
Skin
13%
Platinum
12%
Lymphocytes
12%
Radiotherapy
12%
Therapeutics
11%
Autoimmune Diseases
10%
Immunoconjugates
10%
Immunosuppressive Agents
9%
Ligands
9%
Enzymes
9%
Nectins
9%
Ligation
9%
Bystander Effect
8%
Iodine
8%
Histology
8%
Genes
7%